for HEALTHCARE
PROFESSIONALS
We stand with you,
supporting patients suffering from bone-related pain.
ReBOSSIS began sales in the United States in February 2015. It is used in orthopedic surgeries for trauma and spinal areas and has been highly praised by many orthopedic surgeons for its excellent handling.
In February 2020, we received manufacturing and sales approval in Taiwan and Australia, followed by India in March of the same year. In March 2021, we obtained approval for manufacturing and sales in Japan, and our product has been instrumental in surgeries for many patients suffering from fractures and spinal pain.
Currently, we are gearing up to expand our reach to the significant European market.
Research &
Development
Product Information
ReBOSSIS Product Line
Country of Sales: Japan
Cell Culture Substrate
Stem Cell Extraction Culture Sheet for Research
Efficient Cell Culturing and Cost Reduction
This innovation is
the crystallization of
our bioabsorbable
microfiber technology
Our microfiber scaffolding material manufacturing technology has garnered significant attention from universities, research institutions, and companies involved in regenerative medicine.
The already commercialized “Stem Cell Extraction Culture Sheet for Research” has been shown to accelerate cell proliferation when used as a scaffolding material for cell culture. Its high bioabsorbability allows for the cultured cell sheets to be implanted directly into the body. This innovative approach is expected to revolutionize cell culture, which has traditionally been time-consuming and costly.
